Inducible Clindamycin Resistance in Methicillin Resistant Staphylococcus aureus

Saleh. H. Baiu¹ and Nadia. E. Al-Abdli^2,

¹Department of Botany, Faculty of Science, Benghazi University, Libya

²2Department of Laboratory, Eye Hospital, Benghazi, Libya

Cite this paper:
Saleh. H. Baiu and Nadia. E. Al-Abdli. Inducible Clindamycin Resistance in Methicillin Resistant Staphylococcus aureus. American Journal of Infectious Diseases and Microbiology. 2016; 4(1):25-27. doi: 10.12691/ajidm-4-1-5

Abstract

The resistance to antimicrobial agents among staphylococci is an increasing problem. This has led to renewed interest in the usage of macrolide-lincosamide-streptogramin B (MLSB) antibiotics to treat Staphylococcus aureus infections. In vitro routine tests for clindamycin susceptibility may fail to detect inducible clindamycin resistance thus necessitating the need to detect such resistance by a simple D-test on routine basis. The objective of this study was to investigate S. aureus collected isolates for MLSB phenotypes, in particular inducible clindamycin resistance (MLSBi). Methods: Four hundred and forty six S.aureus isolates from samples were evaluated and inducible resistance to clindamycin was detected by D-test as per CLSI guidelines (2012). Results: Among 224 isolates of staphylococci studied, 101 (21.4%) were methicillin-resistant S. aureus (MRSA) and 123 (26.1%) were methicillin-sensitive Staphylococcus aureus (MSSA). Of the 224 staphylococcal isolates 62 (27.7%) were resistant to erythromycin of which 10 (4.46%) showed inducible clindamycin resistance and belonged to the MLSBi phenotype. Among the 10 MLSBi phenotype 7 (6.93%) were MRSA and 3 (2.44%) were MSSA. Conclusion: D-test should be included as a mandatory method in routine disc diffusion testing to detect inducible clindamycin resistance in staphylococci for the optimum treatment of patients.

Keywords:
staphylococcus inducible clindamycin - resistance D-test

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Al-Abdli, N.E; Baiu, S.H.(2014). Nasal Carriage of Staphylococcus in Health Care Workers in Benghazi Hospitals. American Journal of Microbiological Research, 2 (4): 110-112.
[2]	Chelae,S ; Laohaprertthisarn,V; Phengmak, M; Kongmuang, U; Kalnauwakul,S.(2009).Detection of Inducible Clindamycin Resistance in Staphylococci by Disk Diffusion Induction Test. J Med Assoc Thai ; 92 (7): 947-51.
[3]	Lyall, K. D.S; Gupta, V; Chhina, D. (2013). Inducible clindamycin resistance among clinical isolates of Staphylococcus aureus.Journal of Mahatma Gandhi Institute of Medical Sciences; 18(2): 112-115.
[4]	Ciraj, A.M; Vinod, P;Sreejith, G; Rajani, K.(2009). Inducible clindamycin resistance among clinical isolates of staphylococci. Indian J Pathol Microbiol ; 52:49-51.
[5]	Leclercq, R..(2002). Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin Infect Dis ;34:482-92.
[6]	Drinkovic, D; Fuller, E.R; Shore, K.P;Holland, D.J; Ellis-Pegler, R.(2001)Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother ; 48:315-6.
[7]	Levin, T.P; Suh, B; Axelrod, P; Truant, A.L; Fekete, T. (2005). Potential clindamycin resistance in clindamycin susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother; 49: 1222-4.
[8]	Mane, M; Kadu, A; Gangurde, N. (2012). Inducible Clindamycin Resistance among Staphylococcal Isolates from Different Clinical Samples. International Journal of Health Sciences & Research; 2 (2): 1-7.
[9]	Ahmed, M. O; Abuzweda, A.R; Alghazali, M. H; El ramalli, A.K; Amri, S.G; Aghila, E.Sh; and Abouzeed, Y.M. (2010). Misidentification of Methicillin Resistant Staphylococcus aureus (MRSA) in hospitals in Tripoli, Libya. Citation: Libyan J Med. 5: 5230.
[10]	Chaudhary Anil, B; Shah Krunal, K; Parmar Rosy, J; Kavthia, G.U, Goswami Yogesh, S.(2015). Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. International Journal of Applied Research; 1(9): 922-924.
[11]	Cheesbrough, M, (2009). District Laboratory Practice in Tropical Countries. Cambridge university, UK, 2 (2): (65-67).
[12]	Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing, Twenty-second Informational Supplement. CLSI document M100-S22. Wayne. PA, 2012.
[13]	Deotale,V; Mediratta, D.K; Raut, U. (2010). Inducible Clin-damycin Resistance in Staphylococcus aureus Isolated from Clinical Samples.Indain J Med Microbiology; 28 (2): 124-126.
[14]	Kloos, W.E; Banerman, T.L. (1999). Staphlococcus and Micro-coccus, Chapter22. In: Manual of clinical microbiol-ogy. 7th ed. Murray PR, Baron EJ, Pfaller MA, Tenoer FC, Yolken RH, editors. Washington DC. ASM Press: 264-282.
[15]	Fiebelkorn, K.R; Crawford, S.A; McElmeel, M.L; Jorgensen, J.H. (2003). Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol.;41:4740-4.
[16]	Sureerat, C, Varaporn L; Phengmak M, Urairat K; Sineenart K. (2009). Detection of Inducible Clindamycin Resistance in Staphylococci by Disk Diffusion Induction Test. J Med Assoc Thai; 92 (7): 947-51.
[17]	Moreillon P; Que, Y.A; Glauser, M.P. (2005). Staphylococcus aureus (including staphylococcal toxic shock). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s Principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone, 2321-51.
[18]	Mohanasoundaram, K. M. (2011). The Prevalence Of Inducible Clindamycin Resistance Among Gram Positive Cocci From Various Clinical Specimens Journal of Clinical and Diagnostic Research., 5(1):38-40.